Stroke: does interrupting antiplatelet therapy raise CV risk?
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Discontinuation of antiplatelet therapy is not significantly associated with increased risk for cardiovascular event in patients with acute ischemic stroke.
Why this matters
- Antiplatelet therapy is recommended for long-term secondary stroke prevention, but discontinuation rate...